OICR News / Tag

Machine learning

Browse news tagged Machine learning.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

TechnologyDiagnosis

Researchers uncover evolutionary forces at play in the aging of the blood system and identify people at increased risk of blood cancer

Discovery could provide early warning for blood malignancies, triggering proactive screening and enabling early treatment Toronto – (August 17, 2021) As people age, mutations can build up in blood stem cells and their clones in…

ArticleAug 17, 2021

Collaboration

Ontario experts chart vision to advance machine learning for cancer care

This spring, researchers from across Ontario gathered virtually at the 2021 OICR Translational Research Conference (TRC), including interdisciplinary experts in the use of machine learning (ML) and artificial intelligence for cancer research and eventual clinical…

ArticleMay 20, 2021

TechnologyDiagnosis

AI algorithm classifies cancer types better than experts

Gurnit Atwal and Wei Jiao Pan-Cancer Project researchers develop deep learning system that can determine where a cancer originates with better accuracy than human experts If doctors know where a patient’s cancer started, they can…

ArticleFeb 05, 2020

Talent

OICR welcomes new investigator, Dr. Parisa Shooshtari

Dr. Parisa Shooshtari, OICR Investigator and Assistant Professor in the Schulich School of Medicine and Dentistry at Western University. OICR is proud to welcome Dr. Parisa Shooshtari as an OICR Investigator. Shooshtari specializes in developing…

ArticleSep 03, 2019

TechnologyProstate cancer

Landmark study links tumour evolution to prostate cancer severity

Largest-ever study of its kind uses a tumour’s past to accurately predict its future Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell,…

ArticleApr 19, 2018

Commercialization

FACIT invests $450k in promising Ontario breakthrough technologies

Investment supports emerging entrepreneurial scientists and critical proof-of-principle studies TORONTO, ON (February 20, 2018) – FACIT, a business accelerator, announced four new recipients of funding through its Prospects oncology investment competition: Dalriada Therapeutics Inc. (“Dalriada”),…

ArticleFeb 21, 2018

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Machine learning

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Researchers uncover evolutionary forces at play in the aging of the blood system and identify people at increased risk of blood cancer

Ontario experts chart vision to advance machine learning for cancer care

AI algorithm classifies cancer types better than experts

Cancer solved together — in your inbox

OICR welcomes new investigator, Dr. Parisa Shooshtari

Landmark study links tumour evolution to prostate cancer severity

FACIT invests $450k in promising Ontario breakthrough technologies